Serina Therapeutics Statistics
NYSE: SERHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.010.00 (0.00%)
Market open · Delayed 15 min · as of Oct 8, 11:54 AM ET
Serina Therapeutics by the numbers
Serina Therapeutics has a market capitalization of $51.1 million based on 25.40M shares outstanding. With trailing EPS of $-1.87, Serina Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.7% below its 50-day average and 6.1% below its 200-day average.
Average daily trading volume is 64.02K shares, or about $128,680 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SER valuation vs. peer median
| Metric | SER | Peer median | Difference |
|---|---|---|---|
| Market cap | $51.05M | $50.27M | +2% |
| Avg. volume | 64.02K | 295.82K | -78% |
Peer median across 8 companies: EDSA, ZYBT, ACET, HYPD, DWTX, CRVO, ANVS, TLPH.
Valuation
- Market cap
- $51.05M
- EPS (TTM)
- $-1.87
- Shares outstanding
- 25.40M
Price and trading
- Previous close
- 2.01
- Open
- 2.01
- Day range
- 1.99 – 2.05
- 52-week range
- 1.22 – 5.71
- 52-week change
- -62.78%
- Beta
- —
- Volume
- 27.17K
- Average volume
- 64.02K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 4, 2025
Additional statistics
- Market Cap
- 51.05M
- Forward Pe
- -1.91
- Eps
- -1.87
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.71
- Week52 Low
- 1.22
- Avg Volume
- 64,020.00
- Shares Outstanding
- 25.40M
- Ma50
- 2.38
- Ma200
- 2.14
- Earnings Date
- Aug 4, 2025
- Pct From52w High
- -64.80%
- Pct From52w Low
- 64.75%